CC
IMMU

Centiva Capital’s Immunomedics Inc IMMU Stock Holding History

Centiva Capital’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-87,500
Closed -$7.44M – 1203
2020
Q3 		$7.44M Buy
87,500
+71,961
+463% +$3.64M 0.49% 33
2020
Q2 		$551K Buy
+15,539
New +$454K 0.03% 268

Centiva Capital's IMMU Position: Q4 2020 in Review

Centiva Capital sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 87,500 shares — an estimated $7.44M sold.

Centiva Capital first reported a position in IMMU in Q2 2020 and held it in 2 quarters. The position peaked at $7.44M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Centiva Capital reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Centiva Capital sold 87,500 Immunomedics Inc shares in Q4 2020, an estimated $7.44M.
  • Centiva Capital first reported a position in Immunomedics Inc in Q2 2020 and held it in 2 quarters.
  • Centiva Capital's Immunomedics Inc position peaked at $7.44M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Centiva Capital's 13F filing for Q4 2020, filed 16 Feb 2021.